ESR1 and neoplasm: Previous studies have also found that tumor edge enhancement is closely related to the overexpression of vascular endothelial growth factor and tumor hypoxia, which is common in fast-growing tumors and is related to tumor size, grade, ER and/or PR expression, Ki-67 expression, lymph node status, and DNA S-phase percentage (12, 13).